<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet12771</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-12771</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Научные исследования</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original studies</subject></subj-group></article-categories><title-group><article-title>Метаболический профиль пациентов молодого возраста с первичным гиперпаратиреозом</article-title><trans-title-group xml:lang="en"><trans-title>Metabolic features of young patients with primary hyperparathyroidism</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бибик</surname><given-names>Е. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Bibik</surname><given-names>E. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бибик Екатерина Евгеньевна; eLibrary SPIN: 8522-9466</p><p>Россия, 117036, Москва, ул. Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Ekaterina E. Bibik, MD</p><p>11 Dm. Ulyanova street, 117036 Moscow, Russia</p></bio><email xlink:type="simple">bibikaterina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8916-7346</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Добрева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dobreva</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Добрева Екатерина Александровна, к.м.н.; eLibrary SPIN: 3405-2467</p><p>Москва</p></bio><bio xml:lang="en"><p>Ekaterina A. Dobreva, MD, PhD</p><p>Moscow</p></bio><email xlink:type="simple">dobrevae@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6935-3187</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Айнетдинова</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Ajnetdinova</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Айнетдинова Алина Ринатовна; eLibrary SPIN: 9617-7460</p><p>Москва</p></bio><bio xml:lang="en"><p>Alina R. Ajnetdinova, MD</p><p>Moscow</p></bio><email xlink:type="simple">9803005@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6667-062X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Еремкина</surname><given-names>А. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Eremkina</surname><given-names>A. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Еремкина Анна Константиновна, к.м.н.; eLibrary SPIN: 8848-2660</p><p>Москва</p></bio><bio xml:lang="en"><p>Anna K. Eremkina, MD, PhD</p><p>Moscow</p></bio><email xlink:type="simple">a.lipatenkova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9717-9742</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мокрышева</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Mokrysheva</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мокрышева Наталья Георгиевна, д.м.н., профессор; eLibrary SPIN: 5624-3875</p><p>Москва</p></bio><bio xml:lang="en"><p>Natalia G. Mokrysheva, MD, PhD, Professor</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр эндокринологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>31</day><month>08</month><year>2021</year></pub-date><volume>18</volume><issue>3</issue><fpage>236</fpage><lpage>244</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бибик Е.Е., Добрева Е.А., Айнетдинова А.Р., Еремкина А.К., Мокрышева Н.Г., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Бибик Е.Е., Добрева Е.А., Айнетдинова А.Р., Еремкина А.К., Мокрышева Н.Г.</copyright-holder><copyright-holder xml:lang="en">Bibik E.E., Dobreva E.A., Ajnetdinova A.R., Eremkina A.K., Mokrysheva N.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/12771">https://www.omet-endojournals.ru/jour/article/view/12771</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Основные компоненты минерального обмена способны влиять на неклассические органы-мишени в виде жировой ткани, поджелудочной железы, сосудистой стенки. «Метаболические» эффекты паратиреоидного гормона (ПТГ) и других участников фосфорно-кальциевого обмена в условиях гиперфункции околощитовидных желез остаются до конца не изученными. Исследование нарушений углеводного, жирового и других видов обмена при первичном гиперпаратиреозе (ПГПТ) необходимо для разработки эффективных мер профилактики и лечения пациентов в целях повышения качества и продолжительности жизни населения.</p></sec><sec><title>Цель</title><p>Цель. Изучить основные параметры метаболизма у пациентов молодого возраста в активной стадии ПГПТ до проведения хирургического лечения.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведено одномоментное сравнительное исследование пациентов молодого возраста c ПГПТ и здоровых добровольцев, сопоставимых по полу, возрасту и индексу массы тела (ИМТ). Участникам проведено комплексное биохимическое и гормональное обследование, гиперинсулинемический эугликемический клэмп-тест, оценен состав тела методом биоимпедансометрии.</p></sec><sec><title>Результаты</title><p>Результаты. В исследование включен 21 пациент с ПГПТ и 18 здоровых добровольцев. У больных ПГПТ определяются более высокие значения триглицеридов сыворотки крови (р=0,003) в отсутствие статистически значимых различий по основным параметрам углеводного и пуринового обмена при сравнении с группой контроля. У 42,9% пациентов выявлены признаки висцерального ожирения, в том числе при нормальном ИМТ. Инсулинорезистентность в группе ПГПТ отмечена в 52,4% случаев, при этом показатели М-индекса статистически значимо ниже таковых подгруппы контроля (р=0,008), несмотря на сопоставимый состав тела участников. М-индекс продемонстрировал прямую связь с уровнем фосфора крови (р=0,010) только в общей группе. Определяются статистически значимые положительные корреляции ПТГ, альбумин-скорректированного кальция и остеокальцина с уровнем триглицеридов, кальция — с  гликемией натощак, а также ПТГ — с уровнем мочевой кислоты.</p></sec><sec><title>Заключение</title><p>Заключение. ПГПТ характеризуется формированием у пациентов инсулинорезистентности — основного фактора риска развития серьезных нарушений углеводного и жирового обмена. Прямая связь концентраций ПТГ и кальция крови с уровнем триглицеридов, а также тенденция к гипертриглицеридемии относительно здорового контроля позволяют предполагать влияние заболевания на развитие дислипидемии.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background: The main components of mineral metabolism can influence non-classical target organs such as adipose tissue, pancreas, vascular wall. The «metabolic» effects of parathyroid hormone (PTH) and other participants of phosphorus-calcium metabolism in the hyperfunction of parathyroid glands remain unclear. The study of disorders of carbohydrate, fat and other types of metabolism in primary hyperparathyroidism (PHPT) will help to develop effective measures for prophylaxis and treatment of the patients in order to improve the quality and life span of the population.</p></sec><sec><title>Aim</title><p>Aim: To study the main parameters of metabolism in young patients with an active stage of PHPT before surgical treatment.</p></sec><sec><title>Materials and methods</title><p>Materials and methods: A one-stage comparative study of young patients with PHPT and healthy volunteers matched by sex, age and body mass index (BMI) was carried out. The participants underwent a comprehensive biochemical and hormonal examination, a hyperinsulinemic euglycemic clamp and a bioimpedance analysis of the body composition.</p></sec><sec><title>Results</title><p>Results: 21 patients with PHPT and 18 healthy volunteers were included in the study. Patients with PHPT have higher level of serum triglycerides (p=0.003) without statistically differences of the main carbohydrate and purine parameters comparing with the control group. Visceral obesity were revealed in 42.9% of patients, including those with a normal BMI. Insulin resistance in the PHPT group was noted in 52.4% of cases, while the M-index was statistically lower than in the control subgroup (p=0.008), despite of the comparable body composition of the participants. The M-index showed a positive correlation with blood phosphorus level (p=0.010) only in the general group. Statistically positive correlations of PTH, albumin-corrected calcium and osteocalcin with triglyceride levels, calcium with fasting glycaemia, and PTH with uric acid levels were determined.</p></sec><sec><title>Conclusion</title><p>Conclusion: PHPT is associated with insulin resistance in patients that is the main risk factor for the development of serious carbohydrate and fat disorders. The positive correlation of PTH and blood calcium levels with triglycerides, as well as the tendency to hypertriglyceridemia comparing with healthy volunteers, suggest the disease effect on the development of dyslipidemia.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>первичный гиперпаратиреоз</kwd><kwd>паратгормон</kwd><kwd>кальций</kwd><kwd>инсулинорезистентность</kwd><kwd>сахарный диабет</kwd><kwd>дислипидемия</kwd><kwd>гиперинсулинемический эугликемический клэмп-тест</kwd></kwd-group><kwd-group xml:lang="en"><kwd>primary hyperparathyroidism</kwd><kwd>parathyroid hormone</kwd><kwd>calcium</kwd><kwd>insulin resistance</kwd><kwd>diabetes mellitus</kwd><kwd>dyslipidemia</kwd><kwd>hyperinsulinemic euglycemic clamp</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование проведено при финансовой поддержке Министерства здравоохранения Российской Федерации в рамках выполнения государственного задания «Оптимизация Российского электронного реестра пациентов с первичным гиперпаратиреозом» № НИОКТР 121030100032-7</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Corbetta S, Mantovani G, Spada A. Metabolic Syndrome in Parathyroid Diseases. Front Horm Res. 2018;49:67-84. doi: https://doi.org/10.1159/000486003</mixed-citation><mixed-citation xml:lang="en">Corbetta S, Mantovani G, Spada A. Metabolic Syndrome in Parathyroid Diseases. Front Horm Res. 2018;49:67-84. doi: https://doi.org/10.1159/000486003</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214-223. doi: https://doi.org/10.1152/ajpendo.1979.237.3.E214</mixed-citation><mixed-citation xml:lang="en">DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214-223. doi: https://doi.org/10.1152/ajpendo.1979.237.3.E214</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Майоров А.Ю. Состояние инсулинорезистентности в эволюции сахарного диабета 2 типа: Дис. … док. мед. наук. — Москва; 2009. .</mixed-citation><mixed-citation xml:lang="en">Mayorov A.Y. Sostojanie insulinorezistentnosti v jevoljucii saharnogo diabeta 2 tipa. [dissertation]. Moscow; 2009. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации Министерства здравоохранения Российской Федерации «Первичный гиперпаратиреоз» от 2020 г.</mixed-citation><mixed-citation xml:lang="en">Klinicheskie rekomendacii Ministerstva zdravoohranenija Rossijskoj Federacii “Pervichnyj giperparatireoz” of 2020. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Procopio M, Barale M, Bertaina S, et al. Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine. 2014;47(2):581-589. doi: https://doi.org/10.1007/s12020-013-0091-z</mixed-citation><mixed-citation xml:lang="en">Procopio M, Barale M, Bertaina S, et al. Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine. 2014;47(2):581-589. doi: https://doi.org/10.1007/s12020-013-0091-z</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Мокрышева Н.Г. Первичный гиперпаратиреоз. Эпидемиология, клиника, современные принципы диагностики и лечения: Дис. … док. мед. наук. — Москва; 2011.</mixed-citation><mixed-citation xml:lang="en">Mokrysheva NG. Pervichnyj giperparatireoz. Jepidemiologija, klinika, sovremennye principy diagnostiki i lechenija. [dissertation] Moscow; 2011. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wannamethee SG, Welsh P, Papacosta O, et al. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail. 2014;7(5):732-739. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.114.001272</mixed-citation><mixed-citation xml:lang="en">Wannamethee SG, Welsh P, Papacosta O, et al. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail. 2014;7(5):732-739. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.114.001272</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Мокрышева Н.Г., Добрева Е.А., Мирная С.С., Дедов И.И. Нарушения углеводного и жирового обмена у женщин с первичным гиперпаратиреозом: результаты поперечного исследования // Сахарный диабет. — 2019. — Т. 22. — №1. — С. 8-13.</mixed-citation><mixed-citation xml:lang="en">Mokrysheva NG, Dobreva EA, Mirnaya SS, Dedov II. Carbohydrate and lipid metabolism disorders in women with primary hyperparathyroidism: results of cross-sectional study. Diabetes mellitus. 2019;22(1):8-13. (In Russ.). doi: https://doi.org/10.14341/DM9450</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tassone F, Procopio M, Gianotti L, et al. Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism. Diabet Med. 2009;26(10):968-973. doi: https://doi.org/10.1111/j.1464-5491.2009.02804.x</mixed-citation><mixed-citation xml:lang="en">Tassone F, Procopio M, Gianotti L, et al. Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism. Diabet Med. 2009;26(10):968-973. doi: https://doi.org/10.1111/j.1464-5491.2009.02804.x</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Haap M, Heller E, Thamer C, et al. Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. Eur J Clin Nutr. 2006;60(6):734-739. doi: https://doi.org/10.1038/sj.ejcn.1602375</mixed-citation><mixed-citation xml:lang="en">Haap M, Heller E, Thamer C, et al. Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. Eur J Clin Nutr. 2006;60(6):734-739. doi: https://doi.org/10.1038/sj.ejcn.1602375</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hagstrom E, Hellman P, Lundgren E, et al. Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. Diabetologia. 2007;50(2):317-324. doi: https://doi.org/10.1007/s00125-006-0532-9</mixed-citation><mixed-citation xml:lang="en">Hagstrom E, Hellman P, Lundgren E, et al. Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. Diabetologia. 2007;50(2):317-324. doi: https://doi.org/10.1007/s00125-006-0532-9</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Osadnik K, Osadnik T, Delijewski M, et al. Calcium and Phosphate Levels are Among Other Factors Associated with Metabolic Syndrome in Patients with Normal Weight. Diabetes Metab Syndr Obes. 2020;13:1281-1288. doi: https://doi.org/10.2147/DMSO.S232497</mixed-citation><mixed-citation xml:lang="en">Osadnik K, Osadnik T, Delijewski M, et al. Calcium and Phosphate Levels are Among Other Factors Associated with Metabolic Syndrome in Patients with Normal Weight. Diabetes Metab Syndr Obes. 2020;13:1281-1288. doi: https://doi.org/10.2147/DMSO.S232497</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kim H, Kalkhoff RK, Costrini NV, et al. Plasma insulin disturbances in primary hyperparathyroidism. J Clin Invest. 1971;50(12):2596-2605. doi: https://doi.org/10.1172/JCI106760</mixed-citation><mixed-citation xml:lang="en">Kim H, Kalkhoff RK, Costrini NV, et al. Plasma insulin disturbances in primary hyperparathyroidism. J Clin Invest. 1971;50(12):2596-2605. doi: https://doi.org/10.1172/JCI106760</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sun G, Vasdev S, Martin GR, et al. Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes. 2005;54(11):3336-3339. doi: https://doi.org/10.2337/diabetes.54.11.3336</mixed-citation><mixed-citation xml:lang="en">Sun G, Vasdev S, Martin GR, et al. Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes. 2005;54(11):3336-3339. doi: https://doi.org/10.2337/diabetes.54.11.3336</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Chang E, Donkin SS, Teegarden D. Parathyroid hormone suppresses insulin signaling in adipocytes. Mol Cell Endocrinol. 2009;307(1-2):77-82. doi: https://doi.org/10.1016/j.mce.2009.03.024</mixed-citation><mixed-citation xml:lang="en">Chang E, Donkin SS, Teegarden D. Parathyroid hormone suppresses insulin signaling in adipocytes. Mol Cell Endocrinol. 2009;307(1-2):77-82. doi: https://doi.org/10.1016/j.mce.2009.03.024</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Reusch JE, Begum N, Sussman KE, Draznin B. Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinology. 1991;129(6):3269-3273. doi: https://doi.org/10.1210/endo-129-6-3269</mixed-citation><mixed-citation xml:lang="en">Reusch JE, Begum N, Sussman KE, Draznin B. Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinology. 1991;129(6):3269-3273. doi: https://doi.org/10.1210/endo-129-6-3269</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kanazawa I. Interaction between bone and glucose metabolism [Review]. Endocr J. 2017;64(11):1043-1053. doi: https://doi.org/10.1507/endocrj.EJ17-0323</mixed-citation><mixed-citation xml:lang="en">Kanazawa I. Interaction between bone and glucose metabolism [Review]. Endocr J. 2017;64(11):1043-1053. doi: https://doi.org/10.1507/endocrj.EJ17-0323</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bao Y, Ma X, Yang R, et al. Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men. J Clin Endocrinol Metab. 2013;98(1):345-351. doi: https://doi.org/10.1210/jc.2012-2906</mixed-citation><mixed-citation xml:lang="en">Bao Y, Ma X, Yang R, et al. Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men. J Clin Endocrinol Metab. 2013;98(1):345-351. doi: https://doi.org/10.1210/jc.2012-2906</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Mendonca ML, Batista SL, Nogueira-Barbosa MH, et al. Primary Hyperparathyroidism: The Influence of Bone Marrow Adipose Tissue on Bone Loss and of Osteocalcin on Insulin Resistance. Clinics (Sao Paulo). 2016;71(8):464-469. doi: https://doi.org/10.6061/clinics/2016(08)09</mixed-citation><mixed-citation xml:lang="en">Mendonca ML, Batista SL, Nogueira-Barbosa MH, et al. Primary Hyperparathyroidism: The Influence of Bone Marrow Adipose Tissue on Bone Loss and of Osteocalcin on Insulin Resistance. Clinics (Sao Paulo). 2016;71(8):464-469. doi: https://doi.org/10.6061/clinics/2016(08)09</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Gianotti L, Piovesan A, Croce CG, et al. Interplay between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism. Calcif Tissue Int. 2011;88(3):231-237. doi: https://doi.org/10.1007/s00223-010-9453-1</mixed-citation><mixed-citation xml:lang="en">Gianotti L, Piovesan A, Croce CG, et al. Interplay between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism. Calcif Tissue Int. 2011;88(3):231-237. doi: https://doi.org/10.1007/s00223-010-9453-1</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Paik JM, Farwell WR, Taylor EN. Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int. 2012;23(6):1727-1736. doi: https://doi.org/10.1007/s00198-011-1776-x</mixed-citation><mixed-citation xml:lang="en">Paik JM, Farwell WR, Taylor EN. Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int. 2012;23(6):1727-1736. doi: https://doi.org/10.1007/s00198-011-1776-x</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ponvilawan B, Charoenngam N, Ungprasert P. Primary hyperparathyroidism is associated with a higher level of serum uric acid: A systematic review and meta-analysis. Int J Rheum Dis. 2020;23(2):174-180. doi: https://doi.org/10.1111/1756-185X.13740</mixed-citation><mixed-citation xml:lang="en">Ponvilawan B, Charoenngam N, Ungprasert P. Primary hyperparathyroidism is associated with a higher level of serum uric acid: A systematic review and meta-analysis. Int J Rheum Dis. 2020;23(2):174-180. doi: https://doi.org/10.1111/1756-185X.13740</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Sugimoto R, Watanabe H, Ikegami K, et al. Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism. Kidney Int. 2017;91(3):658-670. doi: https://doi.org/10.1016/j.kint.2016.09.041</mixed-citation><mixed-citation xml:lang="en">Sugimoto R, Watanabe H, Ikegami K, et al. Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism. Kidney Int. 2017;91(3):658-670. doi: https://doi.org/10.1016/j.kint.2016.09.041</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Girardi AC, Titan SM, Malnic G, Reboucas NA. Chronic effect of parathyroid hormone on NHE3 expression in rat renal proximal tubules. Kidney Int. 2000;58(4):1623-1631. doi: https://doi.org/10.1046/j.1523-1755.2000.00323.x</mixed-citation><mixed-citation xml:lang="en">Girardi AC, Titan SM, Malnic G, Reboucas NA. Chronic effect of parathyroid hormone on NHE3 expression in rat renal proximal tubules. Kidney Int. 2000;58(4):1623-1631. doi: https://doi.org/10.1046/j.1523-1755.2000.00323.x</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Carroll R, Matfin G. Endocrine and metabolic emergencies: hypercalcaemia. Ther Adv Endocrinol Metab. 2010;1(5):225-234. doi: https://doi.org/10.1177/2042018810390260</mixed-citation><mixed-citation xml:lang="en">Carroll R, Matfin G. Endocrine and metabolic emergencies: hypercalcaemia. Ther Adv Endocrinol Metab. 2010;1(5):225-234. doi: https://doi.org/10.1177/2042018810390260</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
